Your browser doesn't support javascript.
loading
Mapping glycan-mediated galectin-3 interactions by live cell proximity labeling.
Joeh, Eugene; O'Leary, Timothy; Li, Weichao; Hawkins, Richard; Hung, Jonathan R; Parker, Christopher G; Huang, Mia L.
Afiliación
  • Joeh E; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.
  • O'Leary T; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.
  • Li W; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.
  • Hawkins R; Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458.
  • Hung JR; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.
  • Parker CG; Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458.
  • Huang ML; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.
Proc Natl Acad Sci U S A ; 117(44): 27329-27338, 2020 11 03.
Article en En | MEDLINE | ID: mdl-33067390
ABSTRACT
Galectin-3 is a glycan-binding protein (GBP) that binds ß-galactoside glycan structures to orchestrate a variety of important biological events, including the activation of hepatic stellate cells and regulation of immune responses. While the requisite glycan epitopes needed to bind galectin-3 have long been elucidated, the cellular glycoproteins that bear these glycan signatures remain unknown. Given the importance of the three-dimensional (3D) arrangement of glycans in dictating GBP interactions, strategies that allow the identification of GBP receptors in live cells, where the native glycan presentation and glycoprotein expression are preserved, have significant advantages over static and artificial systems. Here we describe the integration of a proximity labeling method and quantitative mass spectrometry to map the glycan and glycoprotein interactors for galectin-3 in live human hepatic stellate cells and peripheral blood mononuclear cells. Understanding the identity of the glycoproteins and defining the structures of the glycans will empower efforts to design and develop selective therapeutics to mitigate galectin-3-mediated biological events.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / Galectina 3 Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / Galectina 3 Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article